Omega-3 Fatty Acids and Cardiovascular Disease
Publisher: Agency for Healthcare Research and Quality 2016
Number of pages: 1252
There have been hundreds of observational studies and clinical trials conducted to evaluate the effect of omega-3 fatty acids (n-3 FA) on CV disease (CVD) and its risk factors and intermediate markers. The n-3 FA are a group of long-chain and very-long-chain polyunsaturated fatty acids (PUFA) that are substrates for the synthesis of eicosanoids and are important components of cell membranes that impact fluidity.
Home page url
Download or read it online for free here:
by Wilbert S. Aronow (ed.) - InTech
The latest diagnostic and therapeutic modalities in the management of coronary artery disease by coronary artery bypass graft surgery and by percutaneous coronary intervention with stenting have led to a reduction in cardiovascular mortality.
- National Institute for Health and Clinical Excellence
This guideline covers the role of intensive insulin therapy in managing hyperglycaemia within the first 48 hours in people admitted to hospital for acute coronary syndromes. ACS encompass a spectrum of unstable coronary artery disease...
- Royal College of Physicians
This guideline offers advice on the care of adult patients who have symptoms or a diagnosis of chronic heart failure. It aims to define the most effective combination of symptoms, signs and investigations required to establish a diagnosis.
by Takumi Yamada - InTech
Tachycardias can be treated by pharmacological and non-pharmacological approaches. This book covers concerns from basic and clinical points of view and will lead to a further understanding and improvement in the clinical outcomes of tachycardias.